Home » Topics » Regulatory

Regulatory
RSS

SkyePharma's Solaraze earns FDA approval

Oct. 23, 2000

Meningococcal C meningitis vaccine approved for very young infants

Oct. 19, 2000

Dimethaid Research seeks approval for topical osteoarthritis treatment in Canada

Oct. 18, 2000

Glucophage XR: once-daily type 2 diabetes drug approved by FDA

Oct. 18, 2000

Aradigm completes phase II trial with AERx delivery of dornase alfa for CF patients

Oct. 18, 2000

Extended-release Lescol XL cleared by FDA for cholesterol reduction

Oct. 17, 2000

FDA approves Novantrone for worsening forms of multiple sclerosis

Oct. 17, 2000

SangStat obtains technology to develop smaller ciclosporin capsule

Oct. 16, 2000

Remicade recommended for expanded approval in Europe

Oct. 13, 2000

Shire submits NDA for once-daily Adderall for ADHD

Oct. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...